ArticleiScience2024

MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors.

Katrine Ingelshed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.